| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |